This compound is a fluorinated sugar derivative functionalized with benzoate and mesylate groups, serving as a pharmaceutical intermediate for the synthesis of nucleoside analogs. Its structure features a tetrahydrofuran ring with two fluorine atoms and protected hydroxyl groups, making it a valuable building block in medicinal chemistry.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 122111-11-9
2'-O,4'-C-Methyleneguanosine
pharmaceutical intermediate for nucleoside analogs
((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl 4-methylbenzenesulfonate
pharmaceutical intermediate for nucleoside analogs
2'-Deoxy-2'-fluoroguanosine
pharmaceutical intermediate for nucleoside analogs
10-chloro-1,1-diethoxydecane
Pharmaceutical intermediate
6-Chloro-5-iodopyridin-2-amine
Pharmaceutical intermediate for synthesis
N-(2,4-DIMETHYLBENZYL)-3-METHOXYBENZAMIDE
pharmaceutical intermediate
N-Boc-4-amino-2-hydroxybutanoic acid
Pharmaceutical Intermediate
((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate
Pharmaceutical intermediate for nucleoside analogs
[(2R,3R)-3-benzoyloxy-4,4-difluoro-5-methylsulfonyloxyoxolan-2-yl]methyl benzoate
LIAQHZDWFACWFK-QNRNLVPOSA-N
CS(=O)(=O)OC1C([C@@H]([C@H](O1)COC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)(F)F